Skip to main content
. 2019 May 1;36(2):92–107. doi: 10.36141/svdld.v36i2.7163

Table 3.

Contraindications to lung transplantation

Absolute
  • Recent history of malignancy (2-year disease-free interval if low risk of recurrence; 5-year interval for higher risk; risk be remain too high for some cancers beyond 5 years)

  • Severely limited functional capacity with poor rehabilitation potential

  • Significant dysfunction of other major organ systems (unless multiple combined organ transplantation is feasible)

  • Acute medical instability (e.g. acute myocardial infarction, sepsis, hepatic failure)

  • Uncorrectable bleeding diathesis

  • Significant, uncorrected atherosclerotic disease with suspected/confirmed dysfunction (or ischemia or significant coronary artery disease that cannot be revascularized)

  • Chronic infection with highly virulent and/or antibiotic-resistant microbes with poor control pre-transplant

  • Active infection with Mycobacterium tuberculosis

  • Chest wall or spinal deformity that would cause severe ventilator restriction post-transplant

  • Body mass index (BMI) ≥35 kg/m2 (Class II/III obesity)

  • Non-adherence to recommended medical therapies

  • Psychiatric/psychologic conditions causing inability to cooperate with health care team interactions and/or adherence to complex medical therapies

  • Lack of an adequate and/or reliable social support system

  • Substance abuse or dependence (must demonstrate meaningful/persistent risk reduction behaviors and verified abstinence from substances of concern (e.g. tobacco, alcohol, marijuana, or other illicit substances))

Relative
  • Age >65 years if other relative contraindications are present of physiologic reserve is significantly impaired

  • Malnutrition if progressive or severe

  • Osteoporosis if severe, symptomatic

  • BMI 30.0-34.9 kg/m2 (Class I obesity, especially if truncal/central obesity)

  • Extensive prior thoracic surgery (e.g. lung resection)

  • Receiving mechanical ventilation

  • Receiving extracorporeal life support

  • Hepatitis B and/or C infection

  • Human immunodeficiency virus infection

  • Colonization/infection with highly virulent and/or antibiotic-resistant bacteria or fungi

  • Significant atherosclerotic disease burden

  • Other significant medical conditions (e.g. diabetes mellitus, systemic hypertension, gastroesophageal reflux) that have not caused advanced organ system damage (especially if not optimally treated/controlled)